Clinical Trial Update: Safety and Pharmacokinetics of Dapivirine Vaginal Ring in Post-menopausal Women [Phase 2]

View source ↗

Summary

Phase 2 trial update on the safety and pharmacokinetics of a dapivirine vaginal ring in post-menopausal women, completed with results posted in 2022.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Human Immunodeficiency Virus

Drugs mentioned

• Dapivirine vaginal ring (dapivirine)

Snippet

Sponsor: International Partnership for Microbicides, Inc. | Conditions: Human Immunodeficiency Virus | Phase 2 | Status: COMPLETED | Results posted: 2022-10-05